What are the recommended monitoring intervals and criteria for administering antivenom (ASV) in a hospitalized child with suspected snake bite in India?

Observation Frequency and ASV Indications in Hospitalized Children with Suspected Snake Bite in India

All children with suspected snake bite should be observed for a minimum of 24-48 hours regardless of initial clinical presentation, with monitoring every 6 hours for vital signs, local progression, coagulation status (20-minute whole blood clotting time), and systemic signs of envenomation. 1

Monitoring Protocol

Initial Assessment and Observation Period

• Minimum observation: 24-48 hours even without clinical signs of envenomation 1
• Children are particularly vulnerable due to smaller body mass and higher venom-to-body-weight ratio 2
• Delayed presentations are common in rural settings and correlate with worse outcomes 1, 2

Monitoring Intervals

Every 6 hours, assess:

• 20-minute whole blood clotting time (20WBCT) - the primary indicator for hemotoxic envenomation 3, 4
• Vital signs (blood pressure, heart rate, respiratory rate)
• Local progression of swelling/edema beyond the bite site
• Urine output and color (hematuria indicates systemic envenomation) 2
• Neurological signs: ptosis, respiratory difficulty, muscle weakness 2

Laboratory monitoring:

• White blood cell count - elevated WBC correlates with severity 1
• AST/ALT ratio - significantly elevated in severe cases and useful as follow-up criteria 1
• Serum creatinine and renal function (acute kidney injury occurs in ~40% of severe cases) 5, 2
• Serum calcium, albumin, and total protein (hypoproteinemia, hypoalbuminemia, and hypocalcemia correlate with severity) 1
• Creatine kinase (CK) levels 1

Indications for Anti-Snake Venom (ASV) Administration

ASV should be administered when ANY of the following are present:

Absolute Indications

1. Prolonged 20WBCT (>20 minutes) indicating coagulopathy 3, 4, 6
2. Active bleeding manifestations (hematuria, hematemesis, bleeding from gums, epistaxis) - ASV should be guided by bleeding diathesis along with raised clotting time, not clotting time alone 6, 2
3. Neurological signs (ptosis, respiratory paralysis, muscle weakness) - these significantly correlate with mortality 2
4. Systemic signs of envenomation (hypotension, shock, oliguria) 5
5. Acute kidney injury (oliguria, rising creatinine, renal failure) 5, 2

ASV Dosing Protocol for Children

Initial dose: 100 ml polyvalent ASV intravenously 3, 4

Subsequent dosing based on coagulation status:

• If 20WBCT remains prolonged after 6 hours: administer additional doses
• For incoagulable blood at presentation: Higher initial doses (150-200 ml) may be required 4
• Continue ASV every 6 hours until 20WBCT normalizes 3, 4

Critical timing consideration:

• Mortality increases dramatically with delayed ASV administration 7, 2
• Treatment within 6 hours: 0.8% mortality
• Treatment after 12 hours: 38.5% mortality 2
• Early ASV prevents complications regardless of envenomation severity 7

Monitoring After ASV Administration

Continue 6-hourly monitoring because:

• Recurrence of coagulopathy occurs in ~35% of patients even after initial correction 4
• Venom antigenemia can recur, requiring additional ASV doses 4
• Monitor for hypersensitivity reactions to ASV (occur in >50% of cases) 8

Common Pitfalls to Avoid

1. Do not discharge children early - Even without initial signs, envenomation can manifest within 24-48 hours 1

2. Do not rely solely on 20WBCT - ASV indication requires both prolonged clotting time AND bleeding manifestations 6

3. Do not use Indian polyvalent ASV for hump-nosed pit viper (Hypnale hypnale) bites - It provides no benefit and increases complications, ICU stay, and costs 8

4. Do not delay ASV waiting for snake identification - Unidentified snakebites have the highest mortality (20.8%) 2. Treat based on clinical syndrome.

5. Rural occurrence is a risk factor - These children require more intensive monitoring due to delayed presentation 1

Risk Stratification

High-risk features predicting severe envenomation and mortality:

• Prolonged duration before hospital arrival 1, 2
• Rural location of bite 1
• Elevated WBC and AST/ALT ratio 1
• Hypoproteinemia, hypoalbuminemia, hypocalcemia 1
• Respiratory paralysis or ptosis 2
• Renal failure at presentation 2

The dose of ASV is the same for children as adults - dosing is based on venom load, not body weight 9, 2.